Vertex Pharmaceuticals is a biopharmaceutical company based in Boston, Massachusetts, that discovers and develops medicines for serious diseases. Its main business is treating cystic fibrosis with a family of oral drugs that target the underlying protein defects caused by the disease. It also develops and sells gene-editing therapies for blood disorders and has medicines for pain. Its customers are patients, physicians and healthcare systems, mainly in North America, Europe and other markets where its products are approved.
Vertex Pharmaceuticals Inc. trades under the code 0QZU on the London Stock Exchange in UK, with its price quoted in US dollars (USD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Strong price profile
Ranks #435 of 3788 on the London Stock Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendStrong
75/100
Trading above its long-term averages and near its highs.
See the numbers →
Above 200-day average8.2%
From 52-week high-7.0%
MomentumStrong
77/100
Rising faster than most stocks on this exchange.
See the numbers →
3-month return7.8%
6-month return21.0%
12-month, skipping last month24.7%
Stability (higher is calmer)Strong
75/100
Calmer than most: low volatility and shallow drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)29.1%
Worst drawdown, 1 year (smaller is calmer)-15.8%
LiquidityFair
52/100
Moderate trading activity.
See the numbers →
Avg daily value traded0.91M USD
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 403.16 – 577.24Daily closes, split-adjusted
Signals
50-day average523.22
200-day average478.85
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)20.00
Technical summary
Daily
Strongly bullish
11 bullish · 4 neutral · 1 bearish
Weekly
Strongly bullish
10 bullish · 1 neutral · 1 bearish
Monthly
Strongly bullish
7 bullish · 1 neutral · 0 bearish
Moving averages (daily)
SMA 10
513.7
Bullish
EMA 10
515.8
Bullish
SMA 20
510.1
Bullish
EMA 20
514.2
Bullish
SMA 50
523.2
Bearish
EMA 50
513.0
Bullish
SMA 100
504.1
Bullish
EMA 100
502.5
Bullish
SMA 200
478.9
Bullish
EMA 200
485.1
Bullish
Oscillators (daily)
RSI (14)
51.90
Neutral
MACD (12, 26)
0.68
Bullish
Momentum (12)
1.59
Bullish
Stochastic %K (14)
63.41
Neutral
Williams %R (14)
-36.59
Neutral
CCI (20)
49.26
Neutral
Pivot points (classic, last session)
S3
488.3
S2
496.9
S1
507.6
Pivot
516.2
R1
526.9
R2
535.6
R3
546.2
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in USD. Educational only, not financial advice.
